Charleston, SC -- (SBWIRE) -- 09/18/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock:- Galena Biopharma Inc (NASDAQ:GALE), Tellabs, Inc. (NASDAQ:TLAB), EnteroMedics Inc (NASDAQ:ETRM), MFA Financial, Inc. (NYSE:MFA)
Galena Biopharma Inc (NASDAQ:GALE) managed to keep its fall at -0.52% on below -normal volume of 2.18M shares. The stock settled at $1.93 after floating in a range of $3 1.90 to $1.96. Its latest price has reached market capitalization of $162.95 million. Its 52-week range has been $1.23 to $3.
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Has GALE Found The Bottom and Ready To Move Up? Find Out Here
Tellabs, Inc. (NASDAQ:TLAB) traded down on a volume of 2.13 million, lower than its standard daily volume. Shares have dropped-0.43% to $2.34. Over the last twelve months, the stock has lost38.01% and faced a worst price of $1.90.
Tellabs, Inc. designs, develops, and supports telecommunication networking products for communication service providers in the United States and internationally. The company operates through four segments: Optical, Data, Access, and Services.
Has TLAB Found The Bottom And Ready To Gain Momentum? Find Out Here
EnteroMedics Inc (NASDAQ:ETRM) settled 2.46% higher at $1.25 on above-normal volume of 2.11M shares during the last trading day. The stock has its 12-month high at $4.14 and 52-week low price was $0.81. It traded in a range of $1.21 to $1.32 during the last trading day.
EnteroMedics Inc., a development stage medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses.
Why Should Investors Buy ETRM After the Recent Fall? Just Go Here and Find Out
In the last trading session, MFA Financial, Inc. (NYSE:MFA) was up on low volume, trading at a volume of 2.10M shares versus its average daily volume of 3.13 million shares. At $7.52, the stock has attained market capitalization of $2.73 billion.
MFA Financial, Inc., a real estate investment trust (REIT), invests in residential agency and non-agency mortgage-backed securities (MBS). Its MBS are secured by hybrid mortgages, adjustable-rate mortgages, and 15-year and longer term fixed-rate mortgages, as well as by mortgages that have interest rates that reset more frequently.
Will MFA Continue To Move Higher? Find Out Here
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)